growth delay due to insulin-like growth factor I resistance
growth delay due to insulin-like growth factor I resistance
Explore linked clinical trials. Standard reference: MONDO:00100384 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, growth delay due to insulin-like growth factor I resistance, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Early phase 1 | 2026-07-23 | NCT06866548 | |
| Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, growth delay due to insulin-like growth factor I resistance, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Recruiting | Phase 4 | 2025-09-03 | NCT07152392 | |
| Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment. | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, growth delay due to insulin-like growth factor I resistance, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Recruiting | Phase 4 | 2025-09-03 | NCT07152366 | |
| The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment. | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Graves Ophthalmopathy, Graves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, growth delay due to insulin-like growth factor I resistance, hereditary disease, hyperthyroidism, immune system disorder, thyroid gland disorder | Recruiting | Phase 4 | 2025-09-03 | NCT07152340 |